STOCK TITAN

[8-K] Marpai, Inc. Reports Material Event

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
8-K

Marpai, Inc. amended its charter to authorize 2,000,000 shares of blank-check preferred stock. This gives the board the ability to create one or more series of preferred shares with voting powers, preferences, and other rights set solely by the board.

The board approved the amendment on June 24, 2025; a majority of stockholders approved it at the annual meeting on August 27, 2025; and the amendment was filed in Delaware on October 17, 2025.

Marpai, Inc. ha modificato lo statuto per autorizzare 2.000.000 azioni privilegiate in bianco. Questo dà al consiglio la possibilità di creare una o più serie di azioni privilegiate con poteri di voto, preferenze e altri diritti stabiliti esclusivamente dal consiglio.

L'emendamento è stato approvato dal consiglio il 24 giugno 2025; una maggioranza degli azionisti lo ha approvato all'assemblea annuale del 27 agosto 2025; e l'emendamento è stato presentato in Delaware il 17 ottobre 2025.

Marpai, Inc. enmendó su estatuto para autorizar 2.000.000 de acciones preferentes en blanco. Esto da a la junta la capacidad de crear una o más series de acciones preferentes con poderes de voto, preferencias y otros derechos establecidos exclusivamente por la junta.

La junta aprobó la enmienda el 24 de junio de 2025; la mayoría de los accionistas la aprobó en la reunión anual del 27 de agosto de 2025; y la enmienda fue presentada en Delaware el 17 de octubre de 2025.

Marpai, Inc.은 의결권, 우선권 및 기타 권리가 이사회에 의해만 정해지는 하나 이상의 우선주 시리즈를 창출할 수 있도록 회사 정관을 수정했다. 2,000,000주의 백지권한 우선주를 승인한다.

개정안은 2025년 6월 24일 이사회에서 승인되었고; 주주들의 다수는 2025년 8월 27일 연차총회에서 승인했으며; 그리고 개정은 2025년 10월 17일 델라웨어 주에 제출되었다.

Marpai, Inc. a modifié ses statuts pour autoriser 2 000 000 d'actions privilégiées en blanc. Cela donne au conseil le pouvoir de créer une ou plusieurs séries d'actions privilégiées avec des droits de vote, des préférences et d'autres droits établis exclusivement par le conseil.

Le conseil a approuvé l'amendement le 24 juin 2025; une majorité des actionnaires l'a approuvé lors de l'assemblée annuelle du 27 août 2025; et l'amendement a été déposé dans le Delaware le 17 octobre 2025.

Marpai, Inc. hat seine Satzung dahingehend geändert, dass 2.000.000 Vorzugsaktien in Blankoversion ausgegeben werden können. Dies gibt dem Vorstand die Möglichkeit, eine oder mehrere Serien von Vorzugsaktien mit Stimmrechten, Vorzugsrechten und anderen Rechten zu schaffen, die ausschließlich vom Vorstand festgelegt werden.

Der Vorstand hat die Änderung am 24. Juni 2025 genehmigt; eine Mehrheit der Aktionäre hat sie bei der Hauptversammlung am 27. August 2025 genehmigt; und die Änderung wurde am 17. Oktober 2025 in Delaware eingereicht.

Marpai, Inc. عدلت ميثاقها للسماح بإصدار 2,000,000 سهم من الأسهم الممتازة بالبياض. وهذا يمنح المجلس القدرة على إنشاء سلسلة أو أكثر من الأسهم الممتازة ذات حقوق تصويت وتفضيلات وحقوق أخرى يحددها المجلس وحده.

وافق المجلس على التعديل في 24 يونيو 2025؛ ووافق غالبية المساهمين عليه في الاجتماع السنوي في 27 أغسطس 2025؛ وتم تقديم التعديل في Delaware في 17 أكتوبر 2025.

Marpai, Inc. 修订章程,授权发行200万股空白支票优先股。这使董事会有能力创建一名或多名享有投票权、优先权及董事会单独设定的其他权利的优先股系列。

董事会于2025年6月24日批准了该修订;多数股东在2025年8月27日的年度大会上批准;该修订于2025年10月17日向特拉华州提交。

Positive
  • None.
Negative
  • None.

Insights

Charter change adds preferred share flexibility; neutral impact.

Marpai now has authority for 2,000,000 blank-check preferred shares, allowing the board to define series-specific voting rights, preferences, and other terms without further charter changes.

This mechanism can support future financing structures or strategic uses, but any impact depends on whether and how such preferred shares are designated and issued.

Key anchors are the approvals on June 24, 2025 (board) and August 27, 2025 (stockholders), with filing on October 17, 2025. No specific issuance terms are included in the excerpt.

Marpai, Inc. ha modificato lo statuto per autorizzare 2.000.000 azioni privilegiate in bianco. Questo dà al consiglio la possibilità di creare una o più serie di azioni privilegiate con poteri di voto, preferenze e altri diritti stabiliti esclusivamente dal consiglio.

L'emendamento è stato approvato dal consiglio il 24 giugno 2025; una maggioranza degli azionisti lo ha approvato all'assemblea annuale del 27 agosto 2025; e l'emendamento è stato presentato in Delaware il 17 ottobre 2025.

Marpai, Inc. enmendó su estatuto para autorizar 2.000.000 de acciones preferentes en blanco. Esto da a la junta la capacidad de crear una o más series de acciones preferentes con poderes de voto, preferencias y otros derechos establecidos exclusivamente por la junta.

La junta aprobó la enmienda el 24 de junio de 2025; la mayoría de los accionistas la aprobó en la reunión anual del 27 de agosto de 2025; y la enmienda fue presentada en Delaware el 17 de octubre de 2025.

Marpai, Inc.은 의결권, 우선권 및 기타 권리가 이사회에 의해만 정해지는 하나 이상의 우선주 시리즈를 창출할 수 있도록 회사 정관을 수정했다. 2,000,000주의 백지권한 우선주를 승인한다.

개정안은 2025년 6월 24일 이사회에서 승인되었고; 주주들의 다수는 2025년 8월 27일 연차총회에서 승인했으며; 그리고 개정은 2025년 10월 17일 델라웨어 주에 제출되었다.

Marpai, Inc. a modifié ses statuts pour autoriser 2 000 000 d'actions privilégiées en blanc. Cela donne au conseil le pouvoir de créer une ou plusieurs séries d'actions privilégiées avec des droits de vote, des préférences et d'autres droits établis exclusivement par le conseil.

Le conseil a approuvé l'amendement le 24 juin 2025; une majorité des actionnaires l'a approuvé lors de l'assemblée annuelle du 27 août 2025; et l'amendement a été déposé dans le Delaware le 17 octobre 2025.

Marpai, Inc. hat seine Satzung dahingehend geändert, dass 2.000.000 Vorzugsaktien in Blankoversion ausgegeben werden können. Dies gibt dem Vorstand die Möglichkeit, eine oder mehrere Serien von Vorzugsaktien mit Stimmrechten, Vorzugsrechten und anderen Rechten zu schaffen, die ausschließlich vom Vorstand festgelegt werden.

Der Vorstand hat die Änderung am 24. Juni 2025 genehmigt; eine Mehrheit der Aktionäre hat sie bei der Hauptversammlung am 27. August 2025 genehmigt; und die Änderung wurde am 17. Oktober 2025 in Delaware eingereicht.

false --12-31 0001844392 0001844392 2025-10-17 2025-10-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): October 17, 2025

 

MARPAI, INC.

(Exact name of Registrant as Specified in Its Charter)

 

Delaware   001-40904   86-1916231
(State or Other Jurisdiction
of Incorporation)
  (Commission File Number)   (IRS Employer
Identification No.)

 

615 Channelside Drive, Suite 207    
Tampa, Florida   33602
(Address of Principal Executive Offices)   (Zip Code)

 

Registrant’s Telephone Number, Including Area Code: (855) 389-7330

 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Class A Common Stock, par value $0.0001 per share   MRAI   OTCQX Market

  

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

 

On October 17, 2025, Marpai Inc. (the “Company”) filed a Certificate of Amendment (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, pursuant to which the Company’s Amendment to the Second Amended and Restated Certificate of Incorporation (the “Amended Certificate of Incorporation”) was amended to authorize 2,000,000 shares of preferred stock, which shares shall be “blank-check preferred stock” in one or more series as solely determined by the Company’s board of directors (the “Board”), and to have the voting powers, preferences and relative participation, optional and special rights and qualifications, limitations and restrictions thereof as may be solely determined by the Board, from time to time.

 

The Certificate of Amendment was approved by the Board on June 24, 2025, and by a majority of the Company’s stockholders at the Company’s annual stockholders meeting convened on August 27, 2025.

 

The foregoing description of the Certificate of Amendment does not purport to be complete and is qualified in its entirety by reference to the full text of the Certificate of Amendment, a copy of which is filed as Exhibit 3.1 hereto and incorporated by reference herein.

 

 Item 9.01 Financial Statements and Exhibits.

 

Exhibit
Number
  Description
3.1   Amendment to the Second Amended and Restated Certificate of Incorporation of Marpai Inc., dated October 17, 2025
104   Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  MARPAI, INC.
     
Date: October 20, 2025 By: /s/ Damien Lamendola
    Name: Damien Lamendola
    Title: Chief Executive Officer

 

 

2

 

 

Marpai Inc

OTC:MRAI

MRAI Rankings

MRAI Latest News

MRAI Latest SEC Filings

MRAI Stock Data

6.70M
4.05M
49.81%
10.8%
0.16%
Healthcare Plans
Services-misc Health & Allied Services, Nec
Link
United States
TAMPA